Lower expenses tied to COVID, such as travel and group medical, were offset by health and safety costs incurred for the pandemic, strategic spend on technology applications, as well as the addition of acquisitions.

Oct 22, 2020 / CFO / receipt, needs a key / Julie Albrecht, CFO | earnings call 2020-10-22 | transcript f54947fd-ef08-4bc2-a201-c0d99aab840f | chars 4712-4926 | segment 4

SG&A expenses of $121 million were favorable year-over-year by $10 million, driven by a significant focus on reducing controllable costs, as well as the impact of the pandemic to reduce expenses like travel and employee medical.

Jul 16, 2020 / CFO / receipt, needs a key / Julie Albrecht, CFO | earnings call 2020-07-16 | transcript b129f3d3-a59f-41d1-a8b2-9f713fecc3fc | chars 3661-3889 | segment 3